In another Phase II clinical trial also using exenatide, 60 patients participated, with 29 in the placebo group and 31 in the exenatide group
This leads to a very common point of confusion
Regarding sleep disturbances or nightmares specifically, while these are not recognized side effects of tirzepatide, patients experiencing significant sleep problems should discuss them with their healthcare provider
Approximately one-third of patients who do not have satisfactory responses to an SSRI alone will respond when a low-dose D2 Receptor Antagonist is added
This page lists the GLP-1/GIP/glucagon receptor-agonist classification, 4605.1 Da molecular mass, category, SKU, stock status, and 99.95% reported purity for documented lot A1015